Advertisement
Loading...

Eli Lilly and Company

LLY•NYSE
Healthcare
Drug Manufacturers - General
$1004.92
$-1.78(-0.18%)
U.S. Market opens in 27h 1m

Eli Lilly and Company (LLY) Stock Overview

Explore Eli Lilly and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap946.1B
P/E Ratio35.36
EPS (TTM)$28.14
ROE1.01%
Fundamental Analysis

AI Price Forecasts

1 Month$811.60
3 Months$827.25
1 Year Target$1152.87

LLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Eli Lilly and Company (LLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1152.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.36 and a market capitalization of 946.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.20%
5-Day Change
3.14%
1-Month Change
11.008%
3-Month Change
-3.40%
6-Month Change
-2.01%
Year-to-Date (YTD) Change
-6.52%
1-Year Change
37.007%
3-Year Change
131.22%
5-Year Change
413.81%
All-Time (Max) Change
35653.02%

Contact Information

https://www.lilly.com
317 276 2000
Lilly Corporate Center, Indianapolis, IN, 46285

Company Facts

47,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions